Varicella-Zoster Virus (VZV)
Varicella-Zoster Virus (VCV), a member of the human herpesvirus family, causes chicken pox (varicella) and shingles (zoster). More than 90% of the population develops a varicella infection by the time they reach adolescence, and virtually 100% of the population will develop it until the age of 60. When VZV reactivates, it is known as zoster. During their lifetimes, 10-20% of all people will develop zoster.
VZV infections are medically significant, causing approximately 4 million cases of varicella and 500,000 cases of zoster each year.
In immunosuppressed patients the highly infectious Varicella-Zoster Virus causes significant morbidity.
The LightMix® Kit VZV is based on the amplification of the Orf28 gene and provides a fast, easy and accurate system to identify and quantify this target in a nucleic acid extract. A control amplification reaction acts as internal control (IC). This kit has been tested on the LightCycler® 1.x and 2.0 Instruments with Roche Diagnostics ‘LightCycler® FastStart DNA Master HybProbe’.
References
Diagnosis of Variacella-Zoster Virus Infections in the Clinical Laboratory by LightCycler PCR. Espy, et al., Clin. Microbiology 38 (2000) 3187-3189
Kits
- PRNP
- MTHFR C677T
- N. gonorrhoeae
- C. trachomatis
- PAI 1
- PML-RAR
- G6PDH
- U. urealyticum LC
- CYP2D6*3 *5/*5
- CYP2D6*4 *5/*5
- EBV
- L. pneumophila 16S
- AML-ETO
- HHV-8
- Polyoma JC/BK IC
- L. pneumophila MIP
- VZV
- Inf A H5
- M. pneumoniae P1
- inv 16
- Inf A M2
- NAT2
- HHV-6
- CC_530/640
- JAK2 Mut Screening
- ABL1
- HSV
- bcr-abl
- CMV
- B. pertussis / para
- Inf A swine H1
- InfA M2 and H1 sw TaqMan
- Parvovirus B19
- CYP2D6*3*4
- EHEC
